Patent: 6,667,041
✉ Email this page to a colleague
Summary for Patent: 6,667,041
Title: | Use of neurotoxin therapy for treatment of urologic and related disorders |
Abstract: | The present invention relates to methods for treating neurological-urological conditions. This is accomplished by administration of at least one neurotoxin. |
Inventor(s): | Schmidt; Richard A. (Arvada, CO) |
Assignee: | The Regents of the University of Colorado (Boulder, CO) |
Application Number: | 09/978,982 |
Patent Claims: | see list of patent claims |
Details for Patent 6,667,041
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Allergan, Inc. | BOTOX COSMETIC | onabotulinumtoxina | For Injection | 103000 | 12/09/1991 | ⤷ Try a Trial | 2017-07-15 |
Allergan, Inc. | BOTOX | onabotulinumtoxina | For Injection | 103000 | 12/09/1991 | ⤷ Try a Trial | 2017-07-15 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 6,667,041
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 9903483 | ⤷ Try a Trial |
United States of America | 9066943 | ⤷ Try a Trial |
United States of America | 8840905 | ⤷ Try a Trial |
United States of America | 8062643 | ⤷ Try a Trial |
United States of America | 8057807 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |